Alexander S. Parker, Ph.D.

Alexander S. Parker Ph.D.

Professor & Senior Associate Dean for Research

Department: Office of Research Affairs
Business Phone: (904) 244-9620

Clinical Profile

Specialties
  • Epidemiology

Publications

2022
Frailty and risk of mortality in older cancer survivors and adults without a cancer history: Evidence from the National Health and Nutrition Examination Survey, 1999-2014.
Cancer.128(15):2978-2987[DOI] 10.1002/cncr.34258.[PMID] 35608563.
2022
Impact of Medicaid Expansion on Pancreatic Cancer: An Examination of Sociodemographic Disparity in 1-Year Survival.
Journal of the American College of Surgeons.234(1):75-84[DOI] 10.1097/XCS.0000000000000018.[PMID] 35213464.
2022
Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning.
Cancer research.82(15):2792-2806[DOI] 10.1158/0008-5472.CAN-21-2318.[PMID] 35654752.
2022
Novel plasma glycoprotein biomarkers predict progression-free survival in surgically resected clear cell renal cell carcinoma.
Urologic oncology.40(4):168.e11-168.e19[DOI] 10.1016/j.urolonc.2021.12.005.[PMID] 35148948.
2021
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.
Urologic oncology.39(2):135.e1-135.e8[DOI] 10.1016/j.urolonc.2020.08.028.[PMID] 33309297.
2021
Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer.
Clinical epigenetics.13(1):12-[DOI] 10.1186/s13148-020-00998-z.[PMID] 33461589.
2021
Lower disease control rates and survival outcomes among Blacks with pharyngeal squamous cell carcinomas compared with Whites: a retrospective analysis at the University of Florida.
Cancer causes & control : CCC.32(11):1269-1278[DOI] 10.1007/s10552-021-01477-3.[PMID] 34259972.
2020
Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema: A Systematic Review.
Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses.40(2):86-90[DOI] 10.1097/PSN.0000000000000306.[PMID] 32459756.
2020
Breast cancer in women: a descriptive analysis of the national cancer database.
Acta bio-medica : Atenei Parmensis.91(2):332-341[DOI] 10.23750/abm.v91i2.8399.[PMID] 32420970.
2020
Chronic Tenosynovitis of the Upper Extremities Caused by Mycobacterium kansasii : A Clinical Case and Systematic Review of Literature.
Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India.53(1):25-35[DOI] 10.1055/s-0040-1709377.[PMID] 32367915.
2020
Influence of gene expression on survival of clear cell renal cell carcinoma.
Cancer medicine.9(22):8662-8675[DOI] 10.1002/cam4.3475.[PMID] 32986937.
2020
National Analysis of Patients With Ulcerated Melanoma in the United States.
Anticancer research.40(2):1055-1058[DOI] 10.21873/anticanres.14042.[PMID] 32014953.
2019
Delay to Colectomy and Survival for Patients Diagnosed with Colon Cancer.
Journal of investigative surgery : the official journal of the Academy of Surgical Research.32(4):350-357[DOI] 10.1080/08941939.2017.1421732.[PMID] 29351008.
2019
Disparity on Unplanned Readmission in Melanoma Patients: A National Cancer Database Analysis.
Anticancer research.39(12):6877-6880[DOI] 10.21873/anticanres.13906.[PMID] 31810956.
2019
Influence of Facility Characteristics on Access to Breast Reconstruction: A 12-Year National Cancer Database Analysis.
Anticancer research.39(12):6881-6885[DOI] 10.21873/anticanres.13907.[PMID] 31810957.
2019
Osteosarcoma of the Upper Extremities: A National Analysis of the US Population.
Anticancer research.39(10):5663-5668[DOI] 10.21873/anticanres.13763.[PMID] 31570464.
2019
Survival Disparities in Male Patients With Breast Cancer.
Anticancer research.39(10):5669-5674[DOI] 10.21873/anticanres.13764.[PMID] 31570465.
2019
Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma.
Translational cancer research.8(Suppl 4):S397-S403[DOI] 10.21037/tcr.2019.06.36.[PMID] 35117117.
2019
The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.
PLoS medicine.16(1):e1002724-[DOI] 10.1371/journal.pmed.1002724.[PMID] 30605491.
2019
What Factors Define Limb Salvage or Amputation Surgery in Osteosarcoma of the Upper Extremities?
Anticancer research.39(12):6807-6811[DOI] 10.21873/anticanres.13896.[PMID] 31810946.
2019
Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
Anticancer research.39(9):5027-5031[DOI] 10.21873/anticanres.13693.[PMID] 31519610.
2018
Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.
International journal of cancer.142(4):747-756[DOI] 10.1002/ijc.31103.[PMID] 29023769.
2018
Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case-Control Study.
Journal of clinical and experimental hepatology.8(4):375-379[DOI] 10.1016/j.jceh.2018.01.004.[PMID] 30563998.
2018
The Determinants of Palliative Care Use in Patients With Colorectal Cancer: A National Study.
The American journal of hospice & palliative care.35(10):1295-1303[DOI] 10.1177/1049909118765092.[PMID] 29580075.
2017
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.
BMC urology.17(1):19-[DOI] 10.1186/s12894-017-0209-3.[PMID] 28327121.
2017
Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.
European urology.71(6):979-985[DOI] 10.1016/j.eururo.2016.11.018.[PMID] 27899233.
2017
Coffee consumption and risk of renal cell carcinoma.
Cancer causes & control : CCC.28(8):857-866[DOI] 10.1007/s10552-017-0913-z.[PMID] 28647866.
2017
Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma.
Rare tumors.9(2):6834-[DOI] 10.4081/rt.2017.6834.[PMID] 28975018.
2017
GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.
The British journal of radiology.90(1075):20170174-[DOI] 10.1259/bjr.20170174.[PMID] 28486040.
2017
Genome-wide association study identifies multiple risk loci for renal cell carcinoma.
Nature communications.8():15724-[DOI] 10.1038/ncomms15724.[PMID] 28598434.
2017
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.35(32):3706-3713[DOI] 10.1200/JCO.2017.73.3238.[PMID] 28976794.
2017
Timing interval from peri-prostatic block to biopsy impacts procedural pain.
The Canadian journal of urology.24(3):8795-8801[DOI] .[PMID] 28646934.
2016
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer.
PloS one.11(3):e0151785-[DOI] 10.1371/journal.pone.0151785.[PMID] 26986977.
2016
Author Reply.
Urology.89():61-2[DOI] 10.1016/j.urology.2015.10.039.[PMID] 26797576.
2016
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.
The Journal of urology.195(1):180-7[DOI] 10.1016/j.juro.2015.07.113.[PMID] 26300218.
2016
Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
Clinical imaging.40(5):902-6[DOI] 10.1016/j.clinimag.2016.04.008.[PMID] 27183138.
2016
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.29(1):34-42[DOI] 10.1038/modpathol.2015.123.[PMID] 26516698.
2016
Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival.
Urology.89():54-60[DOI] 10.1016/j.urology.2015.10.034.[PMID] 26723183.
2016
Radical Prostatectomy Trends in the United States: 1998 to 2011.
Mayo Clinic proceedings.91(1):10-6[DOI] 10.1016/j.mayocp.2015.09.018.[PMID] 26763510.
2016
Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.
European urology focus.2(6):608-615[DOI] 10.1016/j.euf.2016.03.008.[PMID] 28723492.
2015
A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.
PloS one.10(7):e0132831-[DOI] 10.1371/journal.pone.0132831.[PMID] 26181416.
2015
Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.
Urologic oncology.33(2):68.e17-23[DOI] 10.1016/j.urolonc.2014.07.019.[PMID] 25175426.
2015
Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.
Psycho-oncology.24(4):451-7[DOI] 10.1002/pon.3605.[PMID] 24953309.
2015
Comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.
Journal of surgical oncology.111(4):483-4[DOI] 10.1002/jso.23841.[PMID] 25492622.
2015
Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.
BMC urology.15():58-[DOI] 10.1186/s12894-015-0057-y.[PMID] 26126615.
2015
Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.
Urologic oncology.33(1):23.e9-23.e14[DOI] 10.1016/j.urolonc.2014.10.014.[PMID] 25465300.
2015
Prospective evaluation of the association of adherent perinephric fat with perioperative outcomes of robotic-assisted partial nephrectomy.
Urology.85(4):836-42[DOI] 10.1016/j.urology.2014.12.017.[PMID] 25669734.
2015
Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature.
Rare tumors.7(1):5719-[DOI] 10.4081/rt.2015.5719.[PMID] 25918615.
2015
Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.
Mayo Clinic proceedings.90(3):366-71[DOI] 10.1016/j.mayocp.2015.01.001.[PMID] 25659636.
2015
Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.36(10):7431-7[DOI] 10.1007/s13277-015-3459-2.[PMID] 25900876.
2014
ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma.
BMC urology.14():14-[DOI] 10.1186/1471-2490-14-14.[PMID] 24479813.
2014
Correlation of radiographic renal cell carcinoma tumor volume utilizing computed tomography and magnetic resonance imaging compared with pathological tumor volume.
Scandinavian journal of urology.48(5):453-9[DOI] 10.3109/21681805.2013.876551.[PMID] 24990768.
2014
Evaluation of awareness of risk factors for kidney cancer among patients presenting to a urology clinic.
Scandinavian journal of urology.48(3):239-44[DOI] 10.3109/21681805.2013.863803.[PMID] 24328689.
2014
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.23(9):1804-12[DOI] 10.1158/1055-9965.EPI-14-0029.[PMID] 24920641.
2014
Genomic medicine and incidental findings: balancing actionability and patient autonomy.
Mayo Clinic proceedings.89(6):718-21[DOI] 10.1016/j.mayocp.2014.04.008.[PMID] 24943691.
2014
Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
European urology.66(5):929-35[DOI] 10.1016/j.eururo.2013.12.017.[PMID] 24388441.
2014
Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion.
PloS one.9(6):e96705-[DOI] 10.1371/journal.pone.0096705.[PMID] 24896845.
2014
Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.
Cancer.120(7):1059-67[DOI] 10.1002/cncr.28521.[PMID] 24382589.
2014
MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.
Proteomics.14(7-8):924-35[DOI] 10.1002/pmic.201300434.[PMID] 24497498.
2014
Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy.
European urology.66(6):1165-71[DOI] 10.1016/j.eururo.2014.08.054.[PMID] 25192968.
2014
Prospective evaluation of 24-hour urine profiles following bariatric surgery in a modern comprehensive care bariatric clinic.
Clinical nephrology.81(5):331-7[DOI] 10.5414/CN108154.[PMID] 24495903.
2014
Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.
European urology.66(5):e90-1[DOI] 10.1016/j.eururo.2014.05.009.[PMID] 24877662.
2014
Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma.
Carcinogenesis.35(4):822-7[DOI] 10.1093/carcin/bgt485.[PMID] 24374825.
2013
Age-period-cohort analysis of renal cell carcinoma in United States adults.
Urology.82(1):43-7[DOI] 10.1016/j.urology.2013.02.065.[PMID] 23706585.
2013
Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy.
BMC urology.13():52-[DOI] 10.1186/1471-2490-13-52.[PMID] 24148752.
2013
Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy.
Current urology reports.14(1):26-31[DOI] 10.1007/s11934-012-0292-7.[PMID] 23184624.
2013
Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer.
ISRN oncology.2013():239241-[DOI] 10.1155/2013/239241.[PMID] 23606986.
2013
Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
Psycho-oncology.22(6):1328-35[DOI] 10.1002/pon.3138.[PMID] 22855322.
2013
Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma.
Cancer immunology research.1(6):378-85[DOI] 10.1158/2326-6066.CIR-13-0042.[PMID] 24778130.
2013
Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer.
Journal of radiation oncology.2(3):309-314[DOI] .[PMID] 24073305.
2013
Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume.
Scandinavian journal of urology.47(6):472-5[DOI] 10.3109/21681805.2013.814071.[PMID] 23883351.
2013
Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery.
Journal of the American College of Surgeons.216(3):380-9; quiz 511[DOI] 10.1016/j.jamcollsurg.2012.11.004.[PMID] 23266421.
2012
Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2.
Journal of immunotherapy (Hagerstown, Md. : 1997).35(9):711-5[DOI] 10.1097/CJI.0b013e3182742c27.[PMID] 23090080.
2012
Determination of ureter stent appearance on dual-energy computed tomography scan.
Urology.80(5):986-9[DOI] 10.1016/j.urology.2012.07.005.[PMID] 22921702.
2012
Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?
International urology and nephrology.44(4):1005-12[DOI] 10.1007/s11255-012-0168-2.[PMID] 22528581.
2012
Dorsal vaginal graft urethroplasty for female urethral stricture disease.
BJU international.110(11 Pt C):E1090-5[DOI] 10.1111/j.1464-410X.2012.11233.x.[PMID] 22594612.
2012
Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer.
The Prostate.72(16):1757-66[DOI] 10.1002/pros.22528.[PMID] 22513981.
2012
Expression of endothelin 2 and localized clear cell renal cell carcinoma.
Human pathology.43(6):843-9[DOI] 10.1016/j.humpath.2011.07.011.[PMID] 22047647.
2012
Impact of fellowship training on one-year outcomes of robotic-assisted prostatectomy.
JSLS : Journal of the Society of Laparoendoscopic Surgeons.16(2):195-201[DOI] .[PMID] 23477165.
2012
Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
Urology.80(1):147-50[DOI] 10.1016/j.urology.2012.04.013.[PMID] 22748870.
2012
The effect of robot-assisted laparoscopic prostatectomy on nocturia.
Journal of endourology.26(7):861-5[DOI] 10.1089/end.2011.0611.[PMID] 22332794.
2012
Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
BJU international.110(7):956-60[DOI] 10.1111/j.1464-410X.2012.10937.x.[PMID] 22300498.
2012
Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?
Annals of surgical oncology.19(4):1129-36[DOI] 10.1245/s10434-011-2080-x.[PMID] 21975859.
2011
Estimation of prostate size in community-dwelling men.
Urology.77(2):422-6[DOI] 10.1016/j.urology.2010.05.044.[PMID] 20800880.
2011
Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer.
International journal of radiation oncology, biology, physics.79(5):1343-9[DOI] 10.1016/j.ijrobp.2010.01.061.[PMID] 20598810.
2011
Evaluation of pancreatic damage after extracorporeal shock wave lithotripsy, percutaneous stone surgery, and ureteroscopy.
Urology.77(6):1288-91[DOI] 10.1016/j.urology.2010.08.066.[PMID] 21215433.
2009
Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.18(2):444-53[DOI] 10.1158/1055-9965.EPI-08-1002.[PMID] 19190164.
2009
Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study.
Mayo Clinic proceedings.84(8):702-6[DOI] 10.1016/S0025-6196(11)60520-X.[PMID] 19648387.
2009
Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.
Cancer.115(10):2092-103[DOI] 10.1002/cncr.24263.[PMID] 19296514.
2009
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
International journal of radiation oncology, biology, physics.75(5):1364-70[DOI] 10.1016/j.ijrobp.2008.12.061.[PMID] 19464826.
2008
A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease.
The Journal of biological chemistry.283(26):18344-54[DOI] 10.1074/jbc.M801192200.[PMID] 18407999.
2008
Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.
Human pathology.39(8):1176-84[DOI] 10.1016/j.humpath.2007.12.009.[PMID] 18538369.
2008
Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma.
International journal of urology : official journal of the Japanese Urological Association.15(4):304-8[DOI] 10.1111/j.1442-2042.2008.01994.x.[PMID] 18380816.
2008
Evaluation of the impact of body mass index on outcome among renal mass patients treated with hand-assisted laparoscopic radical nephrectomy.
Journal of endourology.22(2):301-6[DOI] 10.1089/end.2007.0250.[PMID] 18294037.
2008
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.
Cancer.112(7):1471-9[DOI] 10.1002/cncr.23296.[PMID] 18260086.
2008
Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies.
Journal of the National Cancer Institute.100(23):1695-706[DOI] 10.1093/jnci/djn386.[PMID] 19033572.
2007
Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies.
Journal of the National Cancer Institute.99(10):801-10[DOI] .[PMID] 17505075.
2007
Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies.
International journal of cancer.121(10):2246-53[DOI] .[PMID] 17583573.
2007
Re: The epidemiology of renal cell carcinoma.
The Journal of urology.177(5):1953; author reply 1953-4[DOI] .[PMID] 17437854.
2007
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.13(16):4740-9[DOI] .[PMID] 17699851.
2007
Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.13(6):1749-56[DOI] .[PMID] 17363528.
2006
Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
Urology.68(4):741-6[DOI] .[PMID] 17070345.
2006
High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
Cancer.107(1):37-45[DOI] .[PMID] 16736510.
2006
Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.
The Journal of urology.176(3):985-90[DOI] .[PMID] 16890677.
2006
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Cancer research.66(7):3381-5[DOI] .[PMID] 16585157.
2005
Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Clinical cancer research : an official journal of the American Association for Cancer Research.11(14):5128-39[DOI] .[PMID] 16033827.
2005
Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
Urology.65(6):1090-5[DOI] .[PMID] 15893810.
2004
History of urinary tract infection and risk of renal cell carcinoma.
American journal of epidemiology.159(1):42-8[DOI] .[PMID] 14693658.
2004
Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.
Cancer.100(12):2577-82[DOI] .[PMID] 15197799.
2003
Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma.
The Journal of urology.170(2 Pt 1):420-4[DOI] .[PMID] 12853790.
2003
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Cancer.97(7):1663-71[DOI] .[PMID] 12655523.
2003
Smoking cessation and renal cell carcinoma.
Annals of epidemiology.13(4):245-51[DOI] .[PMID] 12684190.
2002
Gender, alcohol consumption, and renal cell carcinoma.
American journal of epidemiology.155(5):455-62[DOI] .[PMID] 11867357.
2002
High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas.
Human pathology.33(8):801-5[DOI] .[PMID] 12203212.

Office Information

Academic Office
6th Floor, Tower II, Suite 6015
580 West 8th Street, T60
Jacksonville, FL 32209
(904) 244-9237
Alexander.Parker@jax.ufl.edu
Administrative Specialist
Nazle Jonnalagadda, M.Ed.
(904) 244-9620
nazle.jonnalagadda@jax.ufl.edu

Education

Ph.D., Epidemiology
2000 · University of Iowa, Iowa City, IA, USA